Amgen Inc

Healthcare
$330.15
-0.68(0.21%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Open PricePrev. CloseVolumeAvg. Volume
$331.88$330.831,688,8332,341,429

Fundamentals

Market Cap$177.10B
P/B Ratio35.3
P/E Ratio47.1
Enterprise Value$231.41B
Div. Yield2.72%
Book Value14.31
EPS(TTM)3.23
ROENA
Understand Fundamentals

About the Company

Amgen, Inc. is a multinational biopharmaceutical company headquartered in California, United States. It was established in the year 1980 as Applied Molecular Genetics, Inc. AMGN shares began trading on the Nasdaq Stock Market in 1983. As of 2020, the company ranked 162nd on Forbes’ list of Global 2000 and 135th on the Fortune 500. Forbes also named Amgen in its Just 100 2021– the list of 100 companies leading a new era of responsible capitalism. Amgen’s net worth is valued at $136.81 billion in 2020. AMGN is one of the world’s leading biotechnology companies, with a history of developing medications for serious and fatal illnesses. In 1989, Amgen received approval by the US Food and Drug Administration (FDA) for its product - Epogen. Epogen is used to treat anaemia caused by treatment with certain HIV drugs, chemotherapy for cancer, and chronic kidney failure. In 1991, FDA approved its drug Neupogen, which prevents infections in cancer patients undergoing chemotherapy. The company acquired Immunex Corporation in a $16 billion deal in 2009. With this acquisition, Amgen added Enbrel to its drug portfolio, the first drug for rheumatoid arthritis. Amgen stock made a significant jump of 2.8% to $241.60 on November 11th 2020, after its drug – Tezepelumab scored a Phase III win in the treatment of severe and uncontrolled asthma. In addition to innovative medicines, the company also undertakes transformative research and biologics manufacturing. Amgen’s migraine treatment was named as one of the Best Inventions of 2018 by TIME Magazine. In 2019, Amgen scored a perfect 100% on Human Rights Campaign Foundation’s Corporate Equality Index. That year, it was also named as one of the happiest companies in America by CareerBliss, for the fourth consecutive year. Amgen also holds a Guinness World Record for most osteoporosis screenings in a day. Amgen Foundation, its philanthropic entity, seeks to enrich communities by advancing excellence in science education, social services, environmental programs, culture and arts.;
OrganisationAmgen Inc
IndustryDrug Manufacturers—General
HeadQuartersThousand Oaks, CA

Company Financials

*All values are in Million $
No Graph Data To Display
Quarterly
Yearly

Similar Stocks

COMPANYMARKET PRICECLOSE PRICEMARKET CAP
Invest the way you want
Join millions of Indians who trust and love Groww
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ